calendar
2,416 catalysts · 3,921 phase readout · 2,133 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 109 grant
2,416 catalysts · 3,921 phase readout · 2,133 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 109 grant
Anticipated earnings call for Nuvalent, Inc. ($NUVL).
Anticipated earnings call for Arcellx, Inc. ($ACLX).
Anticipated earnings call for CG Oncology, Inc. ($CGON).
Anticipated earnings call for Scholar Rock Holding Corp ($SRRK).
Anticipated earnings call for Xenon Pharmaceuticals Inc. ($XENE).
Anticipated earnings call for Lantheus Holdings, Inc. ($LNTH).
Anticipated earnings call for Apellis Pharmaceuticals, Inc. ($APLS).
Anticipated earnings call for Crinetics Pharmaceuticals, Inc. ($CRNX).
Anticipated earnings call for Edgewise Therapeutics, Inc. ($EWTX).
Anticipated earnings call for Structure Therapeutics Inc. ($GPCR).
Anticipated earnings call for Liquidia Corp ($LQDA).
Anticipated earnings call for Dyne Therapeutics, Inc. ($DYN).
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 1.01, 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02
Items: 2.02, 9.01
Items: 5.02, 7.01, 9.01
Items: 2.02
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 5.02, 7.01, 8.01, 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 2.02
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01